Results 101 to 110 of about 49,367 (248)

A Rare Cause of Pheochromocytoma; Neurofibromatosis Type 1-Noonan Syndrome

open access: yes, 2014
Neurofibromatosis (NF) Type 1 (NF-1) is an autosomal dominant disease with a prevalence of about 1/3000. NF-1 is a neurocutaneous syndrome characterized by cafe au lait macules, neurofibroma, optic glioma, lisch nodules, and symptoms involving other ...
Ersen Karakılıç   +7 more
core   +1 more source

Validation of the German version of Infants and Toddlers Dermatology Quality of Life (InToDermQoL) Questionnaire

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Skin diseases can greatly impair quality of life (QoL) of pediatric patients and their families. The Infants and Toddlers Dermatology Quality of Life questionnaire (InToDermQoL) is the first skin‐generic instrument assessing QoL in children ≤ 4 years, as reported by their caregiver. This study aimed to psychometrically
Juliane Traxler   +8 more
wiley   +1 more source

Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex

open access: yesJournal of Patient-Reported Outcomes
Background Almost all patients with Neurofibromatosis type 1 (NF1) develop cutaneous neurofibroma (cNF), benign dermal tumours that have a large impact on the patient’s Quality of Life (QoL).
Britt A. E. Dhaenens   +5 more
doaj   +1 more source

Concurrent validity and agreement of Bayley‐4, AIMS, and HINE assessments in 1‐year‐old children

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
In this cross‐sectional study of children around 1‐year‐old, the Bayley‐4 showed concurrent validity and moderate to substantial agreement with the AIMS and the HINE in both clinical and home settings. Abstract Aim To examine concurrent validity between the Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley‐4) gross motor subtest ...
Weiyang Deng   +14 more
wiley   +1 more source

NEUROFIBROMATOSIS [PDF]

open access: yesAmerican Journal of Roentgenology, 1966
W T, Meszaros, F, Guzzo, H, Schorsch
openaire   +2 more sources

Complete pain relief after bevacizumab in a patient with neurofibromatosis type 2

open access: yes, 2015
Complete pain relief after bevacizumab in a patient with neurofibromatosis type
Attila Kollár (837642)   +7 more
core   +1 more source

A case report of neurofibromatosis [PDF]

open access: yes, 2014
Introduction:Neurofibromatosis is a genetic disease characterized by multifocal benign tumors of peripheral nerves, called neurofibromas, and pigmented spots on the skin which inherited as autosomal-dominant.
Anahita Ghorbani   +7 more
core   +1 more source

Selumetinib as a Target Therapy in Progressive Paediatric Low‐Grade Gliomas—Case Series (pLGG)

open access: yesJournal of Paediatrics and Child Health, EarlyView.
ABSTRACT Background Optic pathway gliomas (OPGs) occur in 15%–20% of children with neurofibromatosis type 1 (NF1). While smaller gliomas may be only monitored, the current standard of care for symptomatic ones relies on chemotherapy, most commonly carboplatin and vincristine.
Laura Trapani   +12 more
wiley   +1 more source

Neurofibromatosis

open access: yes, 1990
The diagnostic criteria, associated problems, genetics, pathogenesis, clinical evaluation and treatment of neurofibromatosis type I in childhood are reviewed from the Department of Pediatrics, Northwestern University Medical School and Children's ...
J Gordon Millichap
core   +1 more source

Building a precision therapeutics program at a tertiary care children's hospital

open access: yes
Pediatric Investigation, EarlyView.
Luke Hamilton   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy